Nanowear

Nanowear

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.nanowearinc.com

Last Round

Accelerator

Oct 16, 2023

Total Funding Raised

$1.68M

Momentum Score

50 /100

Company Overview

Nanowear Inc. is a healthcare technology company that develops and markets an AI-based remote diagnostics platform built on proprietary, cloth-based nanotechnology. The company's flagship product, SimpleSense™, is an FDA-cleared wearable undergarment that captures and analyzes over 85 unique biomarkers related to the heart, lungs, and vascular system. This technology enables continuous, non-invasive, and clinical-grade monitoring of vital signs such as blood pressure, ECG, heart rate, and respiration. Nanowear's platform is designed for use in various settings, including at-home patient management, healthcare facilities, and clinical research, with a focus on managing conditions like hypertension and other cardiopulmonary diseases. The company has received multiple FDA 510(k) clearances for its hardware and Software-as-a-Medical Device (SaMD) platform.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Clinical Trials, Medical AI, Telemedicine

Business Model

B2B

Customer Profile

Hardware + Subscription, Data as a Service, Government Contracts

AI Layer

Application

Keywords

remote patient monitoringRPMcuffless blood pressurenanosensor technologywearable diagnosticsFDA-cleared wearablecardiopulmonary monitoringremote cardiac monitoringAI-enabled wearablesmart textilesmedical wearablesdigital health platformclinical trial dataFDA 510(k) clearancechronic disease managementdecentralized clinical trialspost-surgical monitoring

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nanowear Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nanowear Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
AcceleratorOct 16, 2023
GrantSep 25, 2017
SeedSep 10, 2014

Key People

Founding team and executive leadership

Vijay K. Varadan

Co-Founder, Inventor And Chief Technology Officer

Founding Team

Venk Varadan

Co-Founder CEO

Founding Team

Nanowear Investors

Notable investors and investment history

InvestorRounds
MedTech InnovatorGrant
MAS HoldingsSeed
HealthTech ArkansasAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 15, 2026

    Monthly visitors increased 54% MoM, reaching 1.3K.

  • Mar 1, 2025

    Integrating glucose data from Dexcom G7 into SimpleSense wearable.

Nanowear Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nanowear Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nanowear's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range21
Year Founded2014
Last FundingOct 16, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.